{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T15:02:13Z","timestamp":1787497333039,"version":"build-2736575974"},"reference-count":54,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2010,10,1]],"date-time":"2010-10-01T00:00:00Z","timestamp":1285891200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Drug and Alcohol Dependence"],"published-print":{"date-parts":[[2010,10]]},"DOI":"10.1016\/j.drugalcdep.2010.05.001","type":"journal-article","created":{"date-parts":[[2010,6,12]],"date-time":"2010-06-12T04:34:34Z","timestamp":1276317274000},"page":"241-249","source":"Crossref","is-referenced-by-count":16,"title":["Effect of risperidone on acute methamphetamine-induced hyperthermia in rats"],"prefix":"10.1016","volume":"111","author":[{"given":"Katsutoshi","family":"Shioda","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koichi","family":"Nisijima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tatsuki","family":"Yoshino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satoshi","family":"Kato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.drugalcdep.2010.05.001_bib1","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1007\/s007020100000","article-title":"Effect of low doses of L-NAME on methamphetamine-induced dopaminergic depletion in the rat striatum","volume":"108","author":"Abekawa","year":"2001","journal-title":"J. Neural Transm."},{"key":"10.1016\/j.drugalcdep.2010.05.001_bib2","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1002\/syn.20421","article-title":"Ritanserin reverses repeated methamphetamine-induced behavioral and neurochemical sensitization in mice","volume":"61","author":"Ago","year":"2007","journal-title":"Synapse"},{"key":"10.1016\/j.drugalcdep.2010.05.001_bib3","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1016\/S0022-3565(25)12160-5","article-title":"Methamphetamine-induced hyperthermia and dopaminergic neurotoxicity in mice: pharmacological profile of protective and nonprotective agents","volume":"275","author":"Albers","year":"1995","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.drugalcdep.2010.05.001_bib4","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/S0893-133X(01)00345-1","article-title":"Pharmacological studies of the acute effects of (+)-3,4-methylenedioxymethamphetamine on locomotor activity: role of 5-HT1B\/1D and 5-HT2 receptors","volume":"24","author":"Bankson","year":"2002","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.drugalcdep.2010.05.001_bib5","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1038\/sj.bjp.0707590","article-title":"Role of \u03b11-adrenoceptor subtypes in the effects of methylenedioxy methamphetamine (MDMA) on body temperature in the mouse","volume":"153","author":"Bexis","year":"2008","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.drugalcdep.2010.05.001_bib6","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1007\/s00213-005-0012-9","article-title":"Clozapine increases cutaneous blood flow and reduced sympathetic cutaneous vasomotor altering response (SCVARs) in rats: comparison with effects of haloperidol","volume":"181","author":"Blessing","year":"2005","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.drugalcdep.2010.05.001_bib7","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.1016\/S0022-3565(25)38650-7","article-title":"Further studies of the role of hyperthermia in methamphetamine neurotoxicity","volume":"268","author":"Bowyer","year":"1994","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.drugalcdep.2010.05.001_bib8","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1002\/syn.20130","article-title":"Interactions of dopamine D1 and D2 receptor antagonists with d-methamphetamine-induced hyperthermia and striatal dopamine and serotonin reductions","volume":"56","author":"Broening","year":"2005","journal-title":"Synapse"},{"key":"10.1016\/j.drugalcdep.2010.05.001_bib9","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1016\/S0022-3565(25)10672-1","article-title":"Effects of sulpiride and SCH 23390 on methamphetamine-induced changes in body temperature and lethality","volume":"274","author":"Bronstein","year":"1995","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.drugalcdep.2010.05.001_bib10","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/0893-133X(94)00129-N","article-title":"Radioreceptor binding profile of the atypical antipsychotic olanzapine","volume":"14","author":"Bymaster","year":"1996","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.drugalcdep.2010.05.001_bib11","doi-asserted-by":"crossref","first-page":"2691","DOI":"10.1097\/00001756-199808240-00001","article-title":"Effect of 7-nitroindazole on body temperature and methamphetamine-induced dopamine toxicity","volume":"9","author":"Callahan","year":"1998","journal-title":"Neuroreport"},{"key":"10.1016\/j.drugalcdep.2010.05.001_bib12","doi-asserted-by":"crossref","first-page":"147","DOI":"10.3109\/15563659409000444","article-title":"Fatal and nonfatal methamphetamine intoxication in the intensive care unit","volume":"32","author":"Chan","year":"1994","journal-title":"J. Toxicol. Clin. Toxicol."},{"key":"10.1016\/j.drugalcdep.2010.05.001_bib13","doi-asserted-by":"crossref","first-page":"28089","DOI":"10.1074\/jbc.M303094200","article-title":"Chronic stimulation of D1 dopamine receptors in human SK-N-MC neuroblastoma cells induces nitric-oxide synthase activation and cytotoxicity","volume":"278","author":"Chen","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.drugalcdep.2010.05.001_bib14","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1186\/1471-2458-9-27","article-title":"Use of ecstasy and other psychoactive substances among school-attending adolescents in Taiwan: national surveys 2004\u20132006","volume":"9","author":"Chen","year":"2009","journal-title":"BMC Pub. Health"},{"key":"10.1016\/j.drugalcdep.2010.05.001_bib15","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0165-0173(01)00054-6","article-title":"Methamphetamine neurotoxicity: necrotic and apoptotic mechanisms and relevance to human abuse and treatment","volume":"36","author":"Davidson","year":"2001","journal-title":"Brain Res. Brain Res. Rev."},{"key":"10.1016\/j.drugalcdep.2010.05.001_bib16","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/j.psyneuen.2009.10.001","article-title":"Serotonin 2 receptor modulation of hyperthermia, corticosterone, and hippocampal serotonin depletions following serial exposure to chronic stress and methamphetamine","volume":"35","author":"Doyle","year":"2010","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.drugalcdep.2010.05.001_bib17","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1016\/S0091-3057(97)00308-0","article-title":"Amphetamine-induced locomotor stereotypy in rats is reduced by a D1 but not a D2 antagonist","volume":"58","author":"Fritts","year":"1997","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.drugalcdep.2010.05.001_bib18","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1016\/S0028-3908(03)00209-0","article-title":"Neuroprotective action of MPEP, a selective mGluR5 antagonist, in methamphetamine-induced dopaminergic neurotoxicity is associated with a decrease in dopamine outflow and inhibition of hyperthermia in rats","volume":"45","author":"Go\u0142embiowska","year":"2003","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.drugalcdep.2010.05.001_bib19","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1111\/j.1742-6723.2008.01114.x","article-title":"Review article: amphetamines and related drugs of abuse","volume":"20","author":"Greene","year":"2008","journal-title":"Emerg. Med. Aust."},{"key":"10.1016\/j.drugalcdep.2010.05.001_bib20","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1007\/s00213-004-2030-4","article-title":"Role of the serotonin 5-HT2A receptor in the hyperlocomotive and hyperthermic effects of (+)-3,4-methylenedioxymethamphetamine","volume":"178","author":"Herin","year":"2005","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.drugalcdep.2010.05.001_bib21","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/0014-2999(93)90859-G","article-title":"5-HT2 receptor-mediated potentiation of dopamine synthesis and central serotonergic deficits","volume":"23","author":"Huang","year":"1993","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.drugalcdep.2010.05.001_bib22","first-page":"112","article-title":"The application of immunohistochemical findings in the diagnosis in methamphetamine-related death-two forensic autopsy cases","volume":"50","author":"Ishigami","year":"2003","journal-title":"J. Med. Invest."},{"key":"10.1016\/j.drugalcdep.2010.05.001_bib23","doi-asserted-by":"crossref","first-page":"1770","DOI":"10.1046\/j.1471-4159.1996.67041770.x","article-title":"The neuronal nitric oxide synthase inhibitor, 7-nitroindazole, protects against methamphetamine-induced neurotoxicity in vivo","volume":"67","author":"Itzhak","year":"1996","journal-title":"J. Neurochem."},{"key":"10.1016\/j.drugalcdep.2010.05.001_bib24","doi-asserted-by":"crossref","first-page":"2943","DOI":"10.1097\/00001756-200009110-00022","article-title":"nNOS inhibitors attenuate methamphetamine-induced dopaminergic neurotoxicity but not hyperthermia in mice","volume":"11","author":"Itzhak","year":"2000","journal-title":"Neuroreport"},{"key":"10.1016\/j.drugalcdep.2010.05.001_bib25","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1520\/JFS2003401","article-title":"Use of MDA (the \u201clove drug\u201d) and methamphetamine in Toronto by unsuspecting users of ecstasy (MDMA)","volume":"49","author":"Kalasinsky","year":"2004","journal-title":"J. Forensic Sci."},{"key":"10.1016\/j.drugalcdep.2010.05.001_bib26","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1080\/09595230801919452","article-title":"Crystal methamphetamine smoking among regular ecstasy users in Australia: increases in use and associations with harm","volume":"27","author":"Kinner","year":"2008","journal-title":"Drug Alcohol Rev."},{"key":"10.1016\/j.drugalcdep.2010.05.001_bib27","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/0379-0738(84)90156-7","article-title":"A fatal methamphetamine poisoning associated with hyperpyrexia","volume":"24","author":"Kojima","year":"1984","journal-title":"Forensic Sci. Int."},{"key":"10.1016\/j.drugalcdep.2010.05.001_bib28","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1523\/JNEUROSCI.15-02-01308.1995","article-title":"Hippocampus norepinephrine, caudate dopamine and serotonin, and behavioral responses to the stereoisomers of amphetamine and methamphetamine","volume":"15","author":"Kuczenski","year":"1995","journal-title":"J. Neurosci."},{"key":"10.1016\/j.drugalcdep.2010.05.001_bib29","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1007\/BF02245187","article-title":"Evidence that 1-(2,5-dimethoxy-4-iodophnyl)-2-aminopropane (DOI)-induced hyperthermia in rats is mediated by stimulation of 5-HT2A receptors","volume":"117","author":"Mazzola-Pomietto","year":"1995","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.drugalcdep.2010.05.001_bib30","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/0006-8993(92)90713-J","article-title":"Methamphetamine neurotoxicity and striatal glutamate release: comparison to 3,4-methylenedioxymethamphetamine","volume":"581","author":"Nash","year":"1992","journal-title":"Brain Res."},{"key":"10.1016\/j.drugalcdep.2010.05.001_bib31","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1523\/JNEUROSCI.16-05-01591.1996","article-title":"Psychostimulants depress excitatory synaptic transmission in the nucleus accumbens via presynaptic D1-like dopamine receptors","volume":"16","author":"Nicola","year":"1996","journal-title":"J. Neurosci."},{"key":"10.1016\/j.drugalcdep.2010.05.001_bib32","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1007\/s002130000397","article-title":"Risperidone counteracts lethality in an animal model of the serotonin syndrome","volume":"150","author":"Nisijima","year":"2000","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.drugalcdep.2010.05.001_bib33","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/S0006-8993(00)03020-1","article-title":"Potent serotonin (5-HT)2A receptor antagonists completely prevent the development of hyperthermia in an animal model of the 5-HT syndrome","volume":"890","author":"Nisijima","year":"2001","journal-title":"Brain Res."},{"key":"10.1016\/j.drugalcdep.2010.05.001_bib34","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/S0014-2999(02)02654-7","article-title":"Pharmacological profiles of R-96544: the active form of a novel 5-HT2A receptor antagonist R-102444","volume":"457","author":"Ogawa","year":"2002","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.drugalcdep.2010.05.001_bib35","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/0197-0186(95)00152-2","article-title":"The role of glutamate in behavioral and neurotoxic effects of methamphetamine","volume":"29","author":"Ohmori","year":"1996","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.drugalcdep.2010.05.001_bib36","series-title":"The Rat Brain in Stereotaxic Coordinates","author":"Paxinos","year":"1986"},{"key":"10.1016\/j.drugalcdep.2010.05.001_bib37","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/S0893-133X(01)00333-5","article-title":"5-HT2A and 5-HT2C\/2B receptor subtypes modulate dopamine release induced in vivo by amphetamine and morphine in both the rat nucleus accumbens and striatum","volume":"26","author":"Porras","year":"2002","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.drugalcdep.2010.05.001_bib38","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1038\/sj.npp.1300826","article-title":"Phasic dopaminergic transmission increases NO efflux in the rat dorsal striatum via a neuronal NOS and a dopamine D(1\/5) receptor-dependent mechanism","volume":"31","author":"Sammut","year":"2006","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.drugalcdep.2010.05.001_bib39","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1046\/j.1471-4159.2003.01714.x","article-title":"AR-R17477AR, prevents the loss of NF68 immunoreactivity induced by methamphetamine in the mouse striatum","volume":"85","author":"Sanchez","year":"2003","journal-title":"J. Neurochem."},{"key":"10.1016\/j.drugalcdep.2010.05.001_bib40","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1007\/BF02245606","article-title":"Risperidone compared with new and reference antipsychotic drugs: in vitro and in vivo receptor binding","volume":"124","author":"Schotte","year":"1996","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.drugalcdep.2010.05.001_bib41","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/S0014-2999(01)01188-8","article-title":"Ziprasidone: a novel antipsychotic agent with a unique human receptor binding profile","volume":"425","author":"Schmidt","year":"2001","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.drugalcdep.2010.05.001_bib42","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1111\/j.1749-6632.1996.tb17440.x","article-title":"Nitric oxide is a mediator of methamphetamine (METH)-induced neurotoxicity. In vitro evidence from primary cultures of mesencephalic cells","volume":"801","author":"Sheng","year":"1996","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.drugalcdep.2010.05.001_bib43","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1111\/j.1749-6632.1996.tb17456.x","article-title":"Neurochemical analysis of the psychotoxicity of methamphetamine and cocaine by microdialysis in the rat brain","volume":"801","author":"Shimada","year":"1996","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.drugalcdep.2010.05.001_bib44","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/j.pnpbp.2004.01.013","article-title":"Extracellular serotonin, dopamine and glutamate levels are elevated in the hypothalamus in a serotonin syndrome animal model induced by tranylcypromine and fluoxetine","volume":"28","author":"Shioda","year":"2004","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.drugalcdep.2010.05.001_bib45","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1016\/j.neuro.2008.07.005","article-title":"Risperidone attenuates and reverses hyperthermia induced by 3,4-methylenedioxymethamphetamine (MDMA) in rats","volume":"29","author":"Shioda","year":"2008","journal-title":"Neurotoxicology"},{"key":"10.1016\/j.drugalcdep.2010.05.001_bib46","first-page":"6","article-title":"The psychopharmacology of ziprasidone: receptor-binding properties and real-world psychiatric practice","volume":"64","author":"Stahl","year":"2003","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.drugalcdep.2010.05.001_bib47","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1002\/syn.890170310","article-title":"Methamphetamine-induced neurotoxicity: roles for glutamate and dopamine efflux","volume":"17","author":"Stephans","year":"1994","journal-title":"Synapse"},{"key":"10.1016\/j.drugalcdep.2010.05.001_bib48","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/S0091-3057(03)00194-1","article-title":"Restraint accentuates the effects of 5-HT2 receptor antagonists and a 5-HT1A receptor agonist on lordosis behavior","volume":"76","author":"Uphouse","year":"2003","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.drugalcdep.2010.05.001_bib49","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1097\/00008877-200008000-00001","article-title":"A comparison of the behavioural effects of 5-HT2A and 5-HT2C receptor agonists in the pigeon","volume":"11","author":"Wolff","year":"2000","journal-title":"Behav. Pharmacol."},{"key":"10.1016\/j.drugalcdep.2010.05.001_bib50","doi-asserted-by":"crossref","first-page":"445","DOI":"10.2174\/187152706777950693","article-title":"Pharmacological profile of antipsychotics at monoamine receptors: atypicality beyond 5-HT2A receptor blockade","volume":"5","author":"Wood","year":"2006","journal-title":"CNS Neurol. Disord. Drug Targets"},{"key":"10.1016\/j.drugalcdep.2010.05.001_bib51","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1254\/jjp.48.145","article-title":"The involvement of serotonergic and dopaminergic systems in hypothermia induced in mice by intracerebroventricular injection of serotonin","volume":"48","author":"Yamada","year":"1998","journal-title":"Jpn. J. Pharmacol."},{"key":"10.1016\/j.drugalcdep.2010.05.001_bib52","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1046\/j.1471-4159.1997.68031234.x","article-title":"Simultaneous measurement of nitrite and nitrate levels as indices of nitric oxide release in the cerebellum of conscious rats","volume":"68","author":"Yamada","year":"1997","journal-title":"J. Neurochem."},{"key":"10.1016\/j.drugalcdep.2010.05.001_bib53","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/S0168-0102(97)00032-1","article-title":"Two pathways of nitric oxide production through glutamate receptors in the rat cerebellum in vivo","volume":"28","author":"Yamada","year":"1997","journal-title":"Neurosci. Res."},{"key":"10.1016\/j.drugalcdep.2010.05.001_bib54","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/S0022-3565(25)22061-4","article-title":"Dopaminergic and serotonergic mechanisms of thermoregulation: mediation of thermal effects of apomorphine and dopamine","volume":"227","author":"Yamawaki","year":"1983","journal-title":"J. Pharmacol. Exp. Ther."}],"container-title":["Drug and Alcohol Dependence"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S037687161000164X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S037687161000164X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T17:56:28Z","timestamp":1740160588000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S037687161000164X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,10]]},"references-count":54,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2010,10]]}},"alternative-id":["S037687161000164X"],"URL":"https:\/\/doi.org\/10.1016\/j.drugalcdep.2010.05.001","relation":{},"ISSN":["0376-8716"],"issn-type":[{"value":"0376-8716","type":"print"}],"subject":[],"published":{"date-parts":[[2010,10]]}}}